Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.

McKee JB. et al, (2019), Mult Scler, 25, 246 - 255

Amiloride does not protect retinal nerve fibre layer thickness following acute optic neuritis; result from a phase II, double blind, randomised controlled trial.

McKee JB. et al, (2016), MULTIPLE SCLEROSIS JOURNAL, 22, 21 - 22

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

McKee JB. et al, (2015), BMJ Open, 5

AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM

McKee J. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

Multimodal clinical trial paradigm to assess neuroprotection in optic neuritis: baseline data

Mckee JB. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 361 - 361

Include forthcoming?